Hypothesis: Potential Utility of Pyridoxal 5′-Phosphate (Vitamin B6) and Levamisole in Immune Modulation and HIV-1 Infection

AIDS Patient Care and STDs

Volumn 10, Issue 6, 1996, Pages 353-356

  Salhany, James M ^a   Stevenson, Mario ^b  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; LEVAMISOLE; PYRIDOXINE;

CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOSTIMULATION; LYMPHOPOIESIS; REVIEW; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV-1; HUMANS; LEVAMISOLE; PYRIDOXAL PHOSPHATE; PYRIDOXINE;

EID: 0030481812     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1996.10.353     Document Type: Article

References (31)

1. Hodges, R.E., et al. Factors affecting human antibody response. IV. Pyridoxine deficiency. Am J Clin Nutr 11:180-186, 1962.
2. Robson, L.C., et al. The effects of vitamin B6 deficiency on the lymphoid system and immune responses. In: Vitamin B6 metabolism and role in growth (Tryfiates, C.P., ed.) Food and Nutrition Press, Westport, CT, pp. 205-222, 1980.
3. Kumar, M., Axelrod, A.E. Cellular antibody synthesis in vitamin B6 deficient rats. J Nutr 96:53-59, 1968.
4. 3-uridine by small lymphocytes. Cell Immunol 16:135-144, 1975.
5. Ha, C., et al. The effect of vitamin B6 deficiency on cytotoxic immune responses of T-cells, antibodies and natural killer cells and phagocytosis by macrophages. Cell Immunol 85:318-329, 1984.
6. Baum, M.K., et al. Association of vitamin B6 status with parameters of immune function in early HTV-1 infection. J Acquired Immune Deficiency Syndromes 4:1122-1132, 1991.
7. Salhany, J.M., Schopfer, L.M. Pyridoxal 5′-phosphate binds specifically to soluble CD4 protein, the HTV-1 receptor. Implications for AIDS therapy. J Biol Chem 268:7643-7645, 1993.
8. Guo, L., et al. Inhibition of gp120-CD4 interaction and human immunodeficiency virus type 1 infection in vitro by pyridoxal 5′-phosphate. Antimicrobial Agents and Chemotherapy 38:2483-2487, 1994.
9. Chandra, R.K., Sudhakaran, L. Vitamin B6. Ann NY Acad Sci 585:404-123, 1990.
10. Fauci, A. Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 262:1011-1018, 1993.
11. Dalgleish, A.G., et al. The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London) 312:763-767, 1984.
12. Chavance, M., et al. Vitamin status, immunity and infections in an elderly population. J Clin Nutrition 43:827-835, 1989.
13. 10 and Vitamin B6 for immune responses. Biochem Biophys Res Commun 193:88-92, 1993.
14. Rhodes, J., et al. Therapeutic potential of the immune system by costimulatory Schiff-base forming drugs. Nature 377:71-75, 1995.
15. Fonda, M.L., et al. The binding of pyridoxal 5′-phosphate to human serum albumin. Arch Biochem Biophys 288:79-85, 1991.
16. Speitling, A., et al. Pharmacokinetic properties of the plasma B6 vitamers after single and chronic oral pyridoxine mega doses. Ann New York Acad Sci 585:557-559, 1990.
17. Lui, A., et al. Relationship between body store of vitamin B6 and plasma pyridoxal-P clearance: Metabolic balance studies in humans. J Lab Clin Med 106:491-97, 1985.
18. Whyte, M.P., et al. Markedly increased circulating pyridoxal 5′-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. J Clin Invest 76:752-756, 1985.
19. Whyte, M.P., et al. Perinatal hypophosphatasia: Tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal 5′-phosphate. Evidence for an ectoenzyme role for tissue nonspecific alkaline phosphatase. J Clin Invest 81:1234-1239, 1988.
20. Coburn, S.P., Whyte, M.P. Role of phosphatases in regulation of vitamin B6 metabolism in hypophosphatasia and other disorders. In Leklem, J.E., Reynolds, R.D., eds., Clinical and Physiological Applications of Vitamin B6. New York: Alan R. Liss, Inc., pp. 65-93, 1988.
21. Chodirker, B.N., et al. Increased plasma pyridoxal 5′-phosphate levels before and after pyridoxine loading in carriers of perinatal/infantile hypophosphatasia. J Inher Metab Dis 13:891-896, 1990.
22. Whyte, M.P. Hypophosphatasia. In Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., eds., Metabolic Basis of Inherited Disease (7th Ed.) New York: McGraw-Hill, pp 4095-4111, 1995.
23. Waymire, K.G., et al. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B6. Nature Genetics 11:45-51, 1995.
24. Van Belle, H. Alkaline phosphatase I. Kinetics and inhibition by levamisole of purified isoenzyme from humans. Clin Chem 22:972-977, 1976.
25. Renoux, G. Modulation of immunity by levamisole. J Pharmacol Ther A2:397-423, 1978.
26. Haller, D.G. An overview of adjuvant therapy for colorectal cancer. Eur J Cancer 31A:1255-1263, 1995.
27. Kimball, E.S., Fisher, M.C. Levamisole effects on major histocompatibility complex and adhesion molecule expression and on myeloid cell adhesion to human colon tumor cell lines. J Natl Cancer Inst 88:109-116, 1996.
28. Abdalla, E.E., et al. Mechanism of synergy of levamisole and fluorouracil: Induction of human leukocyte antigen class I in a colorectal cancer cell line. J Natl Cancer Inst 87:489-496, 1995.
29. Schillerr, J.H., et al. Immunological effects of levamisole in vitro. J Immunotherapy 10:297-306, 1991.
30. Renoux, G., Renoux, M. Thymus-like activities of sulphur derivatives on T-cell differentiation. J Exp Med 145:466-471, 1977.
31. Schaumburg, H., et al. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. New Engl J Med 309:445-448, 1983.